SCHEMBL6965173

SCHEMBL6965173

O=c1oc(-c2ccccc2)cc(O)c1SCc1cccc(OCc2ccccc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.52
MAPT P10636 1/20 0.52
CREB1 P16220 1/20 0.45
PRKDC P78527 1/20 0.44
ATM Q13315 1/20 0.44
CYP19A1 P11511 1/20 0.43
ACHE P22303 2/20 0.43
BCHE P06276 1/20 0.43
MAOB P27338 5/20 0.42
TERT O14746 1/20 0.42
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
NAAA Q02083 1/20 0.42
SLC16A3 O15427 1/20 0.42
KDM5A P29375 1/20 0.41
NR4A2 P43354 1/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6954022 0.90 ABCB1 (0.53) ABCB1MAPTCREB1PRKDCCYP19A1
SCHEMBL6966105 0.89 SLC16A3 (0.43) ABCB1MAPTPRKDCACHEMAOB
SCHEMBL6960312 0.89 SMN1; SMN2 (0.41) ABCB1MAPTCREB1MEN1NPC1
SCHEMBL6958533 0.88 DAO (0.47) ABCB1MAPTCYP19A1ACHENPC1
SCHEMBL6955483 0.86 ABCB1 (0.48) ABCB1MAPTCREB1PRKDCATM
SCHEMBL6954786 0.85 SMN1; SMN2 (0.50) ABCB1MAPTCREB1CYP19A1MAOB
SCHEMBL6964536 0.82 DAO (0.46) MAPTMEN1NPC1KMT2A
SCHEMBL6960796 0.82 TNKS (0.47) ABCB1MAPTCYP19A1MAOBTERT
SCHEMBL6965060 0.81 CYP3A4 (0.46) ABCB1MAPTCYP19A1MEN1NPC1
SCHEMBL6952547 0.81 ABCB1 (0.50) ABCB1MAPTCREB1PRKDCACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US claimed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed